Literature DB >> 15063578

Cell death induced by vaccine adjuvants containing surfactants.

Ya-Wun Yang1, Ching-An Wu, W J W Morrow.   

Abstract

Many vaccine adjuvants contain surface-active agents, but the immunological roles played by these components have been essentially ignored. The objective of this study was to examine possible apoptotic and necrotic effects of the surface-active agents, Pluronic L121 and Tween 80, which are components of L121-adjuvant (a formulation we synthesized with the aim of representing several commercially produced adjuvants), on EL4 lymphoma cells. Cell viability and cytolytic effects were analyzed using the MTT and LDH release assays, and the distribution of cells in different stages of the cell cycle after treatment with these agents was analyzed by propidium iodide (PI) staining and flow cytometry. L121-adjuvant was shown to induce cell cycle arrest and inhibit cell proliferation. Treatment of EL4 cells with surface-active agents resulted in a concentration-dependent increase in the apoptotic/necrotic cell populations. Fluorescence microscopy using Hoechst 33342 staining demonstrated chromosome condensation and DNA fragmentation in cells treated with surfactants or adjuvant. The apoptotic and necrotic effects of vaccine adjuvant containing surface-active agents were confirmed by Annexin V/propidium iodide staining and flow cytometric analysis. Pretreatment of EL4 cells with zVAD-fmk, a broad range caspase inhibitor, partially prevented apoptosis induced by Pluronic L121, but did not prevent the cell death induced by Tween 80 or L121-adjuvant. These findings suggested that Tween 80 and L121-adjuvant induced apoptosis in EL4 cells via a "non-classical" caspase-independent pathway. Results presented in this study suggest mechanisms of elicitation of CD8(+), class I-restricted CTL response by soluble antigens mediated by the vaccine adjuvant containing surface-active agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063578     DOI: 10.1016/j.vaccine.2003.08.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.

Authors:  Alexander K Andrianov; Daniel P DeCollibus; Helice A Gillis; Henry H Kha; Alexander Marin; Mark R Prausnitz; Lorne A Babiuk; Hugh Townsend; George Mutwiri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

2.  Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells.

Authors:  Beata U Orzechowska; Jolanta F Kukowska-Latallo; Alexa D Coulter; Zsuzsanna Szabo; Andrzej Gamian; Andrzej Myc
Journal:  Vaccine       Date:  2015-03-25       Impact factor: 3.641

3.  Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Paul E Makidon; Katarzyna W Janczak; Luz P Blanco; Benjamin Swanson; Douglas M Smith; Tiffany Pham; Zsuzsanna Szabo; Jolanta F Kukowska-Latallo; James R Baker
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

4.  Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells.

Authors:  Andrzej Myc; Jolanta F Kukowska-Latallo; Douglas M Smith; Crystal Passmore; Tiffany Pham; Pamela Wong; Anna U Bielinska; James R Baker
Journal:  Vaccine       Date:  2012-12-25       Impact factor: 3.641

5.  Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

Authors:  Christopher B Fox; Susan L Baldwin; Malcolm S Duthie; Steven G Reed; Thomas S Vedvick
Journal:  AAPS PharmSciTech       Date:  2012-03-14       Impact factor: 3.246

6.  Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.

Authors:  Pamela T Wong; Pascale R Leroueil; Douglas M Smith; Susan Ciotti; Anna U Bielinska; Katarzyna W Janczak; Catherine H Mullen; Jeffrey V Groom; Erin M Taylor; Crystal Passmore; Paul E Makidon; Jessica J O'Konek; Andrzej Myc; Tarek Hamouda; James R Baker
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

7.  Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.

Authors:  Alexandra C I Depelsenaire; Stefano C Meliga; Celia L McNeilly; Frances E Pearson; Jacob W Coffey; Oscar L Haigh; Christopher J Flaim; Ian H Frazer; Mark A F Kendall
Journal:  J Invest Dermatol       Date:  2014-04-08       Impact factor: 8.551

8.  Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data.

Authors:  Duk Kyung Kim; Kyeong Hye Won; Seung Hyun Moon; Hak-Kyo Lee
Journal:  Asian-Australas J Anim Sci       Date:  2015-04-06       Impact factor: 2.509

9.  Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.

Authors:  Christopher B Fox; Lucien Barnes V; Tara Evers; James D Chesko; Thomas S Vedvick; Rhea N Coler; Steven G Reed; Susan L Baldwin
Journal:  Influenza Other Respir Viruses       Date:  2012-11-05       Impact factor: 4.380

Review 10.  Squalene emulsions for parenteral vaccine and drug delivery.

Authors:  Christopher B Fox
Journal:  Molecules       Date:  2009-09-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.